327 related articles for article (PubMed ID: 17145528)
1. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.
Pow EH; Kwong DL; McMillan AS; Wong MC; Sham JS; Leung LH; Leung WK
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):981-91. PubMed ID: 17145528
[TBL] [Abstract][Full Text] [Related]
2. Two-year and lifetime cost-effectiveness of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for head-and-neck cancer.
Kohler RE; Sheets NC; Wheeler SB; Nutting C; Hall E; Chera BS
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):683-9. PubMed ID: 24138916
[TBL] [Abstract][Full Text] [Related]
3. The impact of submandibular glands protection on xerostomia as monitored by diffusion-weighted imaging in nasopharyngeal carcinoma patients.
Zhao D; Fan W; Jiang H; Meng L; Cai B; Zhang X; Yu W; Zhao L; Ma L
Strahlenther Onkol; 2024 May; 200(5):377-388. PubMed ID: 37955647
[TBL] [Abstract][Full Text] [Related]
4. LASSO NTCP predictors for the incidence of xerostomia in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
Lee TF; Liou MH; Huang YJ; Chao PJ; Ting HM; Lee HY; Fang FM
Sci Rep; 2014 Aug; 4():6217. PubMed ID: 25163814
[TBL] [Abstract][Full Text] [Related]
5. Acupuncture for Chronic Radiation-Induced Xerostomia in Head and Neck Cancer: A Multicenter Randomized Clinical Trial.
Cohen L; Danhauer SC; Garcia MK; Dressler EV; Rosenthal DI; Chambers MS; Cusimano A; Brown WM; Ochoa JM; Yang P; Chiang JS; Gordon O; Crutcher R; Kim JK; Russin MP; Lukenbill J; Porosnicu M; Yost KJ; Weaver KE; Lesser GJ
JAMA Netw Open; 2024 May; 7(5):e2410421. PubMed ID: 38739392
[TBL] [Abstract][Full Text] [Related]
6. Randomized Double-Blind Placebo-Controlled Study of Salivary Substitute with Enzymatic System for Xerostomia in Patients Irradiated in Head and Neck Region.
Porangaba LP; de Melo Garcia F; Rabelo APAA; Andrade AP; de Abreu Alves F; Pellizzon ACA; Jaguar GC
Curr Oncol; 2024 Feb; 31(2):1102-1112. PubMed ID: 38392076
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in patients with nasopharyngeal carcinoma receiving IMRT vs IMPT: a multicenter prospective longitudinal study.
Chung CF; Huang BS; Wang YM; Huang YT; Chen SC
Support Care Cancer; 2024 Mar; 32(3):203. PubMed ID: 38430411
[TBL] [Abstract][Full Text] [Related]
8. Salivary Electrostimulation in the Treatment of Radiation Therapy-Induced Xerostomia (LEONIDAS-2): A Multicenter, Randomized, Double-Masked, Sham-Controlled, Phase 3 Trial.
Mercadante V; Hamad AA; McCaul J; Nutting C; Harrington K; Carnell D; Urbano TG; Kalavrezos N; Barber JA; Porter SR; Fedele S
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):142-153. PubMed ID: 36933846
[TBL] [Abstract][Full Text] [Related]
9. A Prospective Study of the Incidence of Chronic Xerostomia and the Quality of Life in Patients Undergoing Radiotherapy for Head and Neck Malignancies with IMRT or VMAT Techniques.
Pathak NG; P M; Alok Y
Gulf J Oncolog; 2024 Jan; 1(44):39-47. PubMed ID: 38205571
[TBL] [Abstract][Full Text] [Related]
10. Effect of Percutaneous Endoscopic Gastrostomy on Quality of Life after Chemoradiation for Locally Advanced Nasopharyngeal Carcinoma: A Cross-Sectional Study.
Xu Y; Peng H; Guo Q; Guo L; Peng X; Lin S
Curr Oncol; 2023 Jan; 30(1):1000-1009. PubMed ID: 36661725
[TBL] [Abstract][Full Text] [Related]
11. Assessment and management of radiation-induced trismus in patients with nasopharyngeal carcinoma: a best practice implementation project.
Zhang L; Wang L; Wu Y; Zhou C; Zhang L; He L; Zhang C; Liu L; He L; Chen C; Du Z; Li Z; Chen P
JBI Evid Implement; 2023 Sep; 21(3):208-217. PubMed ID: 36374997
[TBL] [Abstract][Full Text] [Related]
12. Palliative radiotherapy for leptomeningeal metastases after photon-based intensity-modulated radiotherapy in a nasopharyngeal cancer patient.
Marlina YS; Novirianthy R; Beočanin A
Narra J; 2023 Dec; 3(3):e266. PubMed ID: 38455636
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Radiation-induced Xerostomia in Patients with Nasopharyngeal Carcinomas.
Mohammadi N; Seyyednejhad F; Alizadeh Oskoee P; Savadi Oskoee S; Mofidi N
J Dent Res Dent Clin Dent Prospects; 2007; 1(2):65-70. PubMed ID: 23277836
[TBL] [Abstract][Full Text] [Related]
14. Patient-reported outcomes of taste alterations and quality of life in patients with nasopharyngeal carcinoma.
Li J; Shao X; Yu R; Shi L; Xu D; Yu X
Pak J Med Sci; 2023; 39(6):1751-1756. PubMed ID: 37936744
[TBL] [Abstract][Full Text] [Related]
15. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients.
Kam MK; Leung SF; Zee B; Chau RM; Suen JJ; Mo F; Lai M; Ho R; Cheung KY; Yu BK; Chiu SK; Choi PH; Teo PM; Kwan WH; Chan AT
J Clin Oncol; 2007 Nov; 25(31):4873-9. PubMed ID: 17971582
[TBL] [Abstract][Full Text] [Related]
16. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.
Nutting CM; Morden JP; Harrington KJ; Urbano TG; Bhide SA; Clark C; Miles EA; Miah AB; Newbold K; Tanay M; Adab F; Jefferies SJ; Scrase C; Yap BK; A'Hern RP; Sydenham MA; Emson M; Hall E;
Lancet Oncol; 2011 Feb; 12(2):127-36. PubMed ID: 21236730
[TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma.
Peng G; Wang T; Yang KY; Zhang S; Zhang T; Li Q; Han J; Wu G
Radiother Oncol; 2012 Sep; 104(3):286-93. PubMed ID: 22995588
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225.
Lee N; Harris J; Garden AS; Straube W; Glisson B; Xia P; Bosch W; Morrison WH; Quivey J; Thorstad W; Jones C; Ang KK
J Clin Oncol; 2009 Aug; 27(22):3684-90. PubMed ID: 19564532
[TBL] [Abstract][Full Text] [Related]
19. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.
Al-Sarraf M; LeBlanc M; Giri PG; Fu KK; Cooper J; Vuong T; Forastiere AA; Adams G; Sakr WA; Schuller DE; Ensley JF
J Clin Oncol; 1998 Apr; 16(4):1310-7. PubMed ID: 9552031
[TBL] [Abstract][Full Text] [Related]
20. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ
J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
